Impact of perinatal corticosteroids on neuromotor development and outcome: Review of the literature and new meta-analysis

Seminars in Fetal and Neonatal Medicine

Volumn 14, Issue 3, 2009, Pages 164-170

  Shinwell, E S ^a   Eventov Friedman, S ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Bronchopulmonary dysplasia; Cerebral palsy; Corticosteroids; Dexamethasone; Preterm infants

Indexed keywords

BETAMETHASONE; CORTICOSTEROID; DEXAMETHASONE; HYDROCORTISONE; PLACEBO;

ARTICLE; CASE CONTROL STUDY; CEREBRAL PALSY; CLINICAL TRIAL; COHORT ANALYSIS; DRUG USE; EXTREMELY LOW BIRTH WEIGHT; HISTORY; HUMAN; LUNG DYSPLASIA; MEDICAL LITERATURE; META ANALYSIS; MOTONEURON; MOTOR DEVELOPMENT; NERVE CELL DIFFERENTIATION; OUTCOME ASSESSMENT; PERINATAL PERIOD; REGRESSION ANALYSIS; SYSTEMATIC REVIEW;

BRONCHOPULMONARY DYSPLASIA; CHILD DEVELOPMENT; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; META-ANALYSIS AS TOPIC; PERINATAL CARE; PREGNANCY; PRENATAL CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 62849104567     PISSN: 1744165X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.siny.2008.12.001     Document Type: Article

References (75)

1. Haddad H.M., Hsia D.Y., and Gellis S.S. Studies on respiratory rate in the newborn; its use in the evaluation of respiratory distress in infants of diabetic mothers. Pediatrics 17 (1956) 204-213
2. Baden M., Bauer C.R., Colle E., Klein G., Taeusch Jr. H.W., and Stern L. A controlled trial of hydrocortisone therapy in infants with respiratory distress syndrome. Pediatrics 50 (1972) 526-534
3. Merritt T.A., Stuard I.D., Puccia J., et al. Newborn tracheal aspirate cytology: classification during respiratory distress syndrome and bronchopulmonary dysplasia. J Pediatr 98 (1981) 949-956
4. Avery G.B., Fletcher A.B., Kaplan M., and Brudno D.S. Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics 75 (1985) 106-111
5. Shinwell E.S., Karplus M., and Reich D. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed 83 (2000) F177-F181
6. O'Shea T.M., Kothadia J.M., and Klinepeter. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics 104 (1999) 15-21
7. Yeh T.F., Lin Y.J., Huang C.C., et al. Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics 101 (1998) E7
8. Shinwell E.S., Karplus M., Bader D., et al. Neonatologists are using much less dexamethasone. Arch Dis Child Fetal Neonatal Ed 88 (2003) F432-F433
9. Walsh M.C., Yao Q., Horbar J.D., Carpenter J.H., Lee S.K., and Ohlsson A. Changes in the use of postnatal steroids for bronchopulmonary dysplasia in 3 large neonatal networks. Pediatrics 118 (2006) e1328-e1335
10. American Academy of Pediatrics Guideline. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 109 (2002) 330-338
11. Halliday H.L., Ehrenkranz R.A., and Doyle L.W. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev (2003) CD001146
12. Halliday H.L., Ehrenkranz R.A., and Doyle L.W. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev (2003) CD001144
13. Halliday H.L., Ehrenkranz R.A., and Doyle L.W. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev (2003) CD001145
14. Doyle L.W., Davis P.G., Morley C.J., McPhee A., and Carlin J.B. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial. Pediatrics 117 (2006) 75-83
15. Onland W., De Jaegere A.P., Offringa M., and van Kaam A.H. Effects of higher versus lower dexamethasone doses on pulmonary and neurodevelopmental sequelae in preterm infants at risk for chronic lung disease: a meta-analysis. Pediatrics 122 (2008) 92-101
16. Halliday H.L., Patterson C.C., and Halahakoon C.W. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Pediatrics 107 (2001) 232-240
17. Wilson-Costello D., and Walsh M.C. Benchmarking subcommittee, NICHD Neonatal Research Network. Impact of postnatal corticosteroid PNS dose and timing in extremely low birthweight infants (ELBW) on neurodevelopment at 18-22 months. E-PAS 59 (2006) 4355
18. Wood N.S., Costeloe K., Gibson A.T., Hennessy E.M., Marlow N., and Wilkinson A.R. The EPICure study: associations and antecedents of neurological and developmental disability at 30 months of age following extremely preterm birth. Arch Dis Child Fetal Neonatal Ed 90 (2005) F134-F140
19. Vincer M.J., Allen A.C., Joseph K.S., Stinson D.A., Scott H., and Wood E. Increasing prevalence of cerebral palsy among very preterm infants: a population-based study. Pediatrics 118 (2006) e1621-e1626
20. Postnatal corticosteroids and sensorineural outcome at 5 years of age. J Paediatr Child Health 36 (2000) 256-261
21. Rijken M., Stoelhorst G.M., Martens S.E., et al. Mortality and neurologic, mental, and psychomotor development at 2 years in infants born less than 27 weeks' gestation: the Leiden follow-up project on prematurity. Pediatrics 112 (2003) 351-358
22. Neurodevelopmental outcomes of extreme-low-birth-weight infants born between 2001 and 2002. Hong Kong Med J 14 (2008) 21-28
23. Takahashi R., Yamada M., Takahashi T., et al. Risk factors for cerebral palsy in preterm infants. Early Hum Dev 81 (2005) 545-553
24. Powell K., Kerkering K.W., Barker G., and Rozycki H.J. Dexamethasone dosing, mechanical ventilation and the risk of cerebral palsy. J Matern Fetal Neonatal Med 19 (2006) 43-48
25. Needelman H., Evans M., Roberts H., Sweney M., and Bodensteiner J.B. Effects of postnatal dexamethasone exposure on the developmental outcome of premature infants. J Child Neurol 23 (2008) 421-424
26. Barrington K.J. The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs. BMC Pediatr 1 (2001) 1
27. Doyle L.W., Halliday H.L., Ehrenkranz R.A., Davis P.G., and Sinclair J.C. Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk for chronic lung disease. Pediatrics 115 (2005) 655-661
28. Doyle L.W., Davis P.G., Morley C.J., McPhee A., and Carlin J.B. Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomized, controlled trial of low-dose dexamethasone. Pediatrics 119 (2007) 716-721
29. O'Shea T.M., Washburn L.K., Nixon P.A., and Goldstein D.J. Follow-up of a randomized, placebo-controlled trial of dexamethasone to decrease the duration of ventilator dependency in very low birth weight infants: neurodevelopmental outcomes at 4 to 11 years of age. Pediatrics 120 (2007) 594-602
30. Gross S.J., Anbar R.D., and Mettelman B.B. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease. Pediatrics 115 (2005) 681-687
31. Jones R.A., and Collaborative Dexamethasone Trial Follow-up Group. Randomized, controlled trial of dexamethasone in neonatal chronic lung disease: 13- to 17-year follow-up study: I. Neurologic, psychological, and educational outcomes. Pediatrics 116 (2005) 370-378
32. Yeh T.F., Lin Y.J., Lin H.C., et al. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. N Engl J Med 350 (2004) 1304-1313
33. Yeh T.F., Lin Y.J., Hsieh W.S., et al. Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial. Pediatrics 100 (1997) E3
34. Wilson D.M., Baldwin R.B., and Ariagno R.L. A randomized, placebo-controlled trial of effects of dexamethasone on hypothalamic-pituitary-adrenal axis in preterm infants. J Pediatr 113 (1988) 764-768
35. Brozanski B.S., Jones J.G., Gilmour C.H., et al. Effect of pulse dexamethasone therapy on the incidence and severity of chronic lung disease in the very low birth weight infant. J Pediatr 126 (1995) 769-776
36. Harkavy K.L., Scanlon J.W., Chowdhry P.K., and Grylack L.J. Dexamethasone therapy for chronic lung disease in ventilator- and oxygen-dependent infants: a controlled trial. J Pediatr 115 (1989) 979-983
37. Kovacs L., Davis G.M., Faucher D., and Papageorgiou A. Efficacy of sequential early systemic and inhaled corticosteroid therapy in the prevention of chronic lung disease of prematurity. Acta Paediatr 87 (1998) 792-798
38. Ohlsson A., Calvert S.A., Hosking M., and Shennan A.T. Randomized controlled trial of dexamethasone treatment in very-low-birth-weight infants with ventilator-dependent chronic lung disease. Acta Paediatr 81 (1992) 751-756
39. Romagnoli C., Zecca E., Luciano R., Torrioli G., and Tortorolo G. A three year follow up of preterm infants after moderately early treatment with dexamethasone. Arch Dis Child Fetal Neonatal Ed 87 (2002) F55-F58
40. Romagnoli C., Zecca E., Luciano R., Torrioli G., and Tortorolo G. Controlled trial of early dexamethasone treatment for the prevention of chronic lung disease in preterm infants: a 3-year follow-up. Pediatrics 109 (2002) e85
41. Sanders R.J., Cox C., Phelps D.L., and Sinkin R.A. Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome. Pediatr Res 36 (1994) 122-128
42. Sinkin R.A., Dweck H.S., Horgan M.J., et al. Early dexamethasone-attempting to prevent chronic lung disease. Pediatrics 105 (2000) 542-548
43. Stark A.R., Carlo W.A., Tyson J.E., et al. Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med 344 (2001) 95-101
44. Subhedar N.V., Ryan S.W., and Shaw N.J. Open randomised controlled trial of inhaled nitric oxide and early dexamethasone in high risk preterm infants. Arch Dis Child Fetal Neonatal Ed 77 (1997) F185-F190
45. Vincer M.J., and Allen A.C. Double blind randomized controlled trial of 6-day pluse of dexamethasone for very low birth weight infants (VLBW <1500 grams) who are ventilator dependent at 4 weeks of age. Pediatr Res 43 (1998) 201A
46. Vohr B.R., Wright L.L., Poole W.K., and McDonald S.A. Neurodevelopmental outcomes of extremely low birth weight infants <32 weeks' gestation between 1993 and 1998. Pediatrics 116 (2005) 635-643
47. Tyson J.E., Parikh N.A., Langer J., and Higgins R.D. Intensive care for extreme prematurity -moving beyond gestational age. N Engl J Med 358 (2008) 1672-1681
48. Matthews S.G. Dynamic changes in glucocorticoid and mineralocorticoid receptor mRNA in the developing guinea pig brain. Brain Res Dev Brain Res 107 (1998) 123-132
49. Robertson C.M., Watt M.J., and Yasui Y. Changes in the prevalence of cerebral palsy for children born very prematurely within a population-based program over 30 years. J Am Med Assoc 297 (2007) 2733-2740
50. Platt M.J., Cans C., Johnson A., et al. Trends in cerebral palsy among infants of very low birthweight (<1500 g) or born prematurely (<32 weeks) in 16 European centres: a database study. Lancet 369 (2007) 43-50
51. Polyakov A., Cohen S., Baum M., Trickey D., Jolley D., and Wallace E.M. Patterns of antenatal corticosteroid prescribing 1998-2004. Aust N Z J Obstet Gynaecol 47 (2007) 42-45
52. Fanaroff A.A., Hack M., and Walsh M.C. The NICHD neonatal research network: changes in practice and outcomes during the first 15 years. Semin Perinatol 27 (2003) 281-287
53. Wilson-Costello D., Friedman H., Minich N., et al. Improved neurodevelopmental outcomes for extremely low birth weight infants in 2000-2002. Pediatrics 119 (2007) 37-45
54. Hintz S.R., Kendrick D.E., Vohr B.R., Poole W.K., and Higgins R.D. Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999. Pediatrics 115 (2005) 1645-1651
55. Costeloe K., Hennessy E., Gibson A.T., Marlow N., and Wilkinson A.R. The EPICure study: outcomes to discharge from hospital for infants born at the threshold of viability. Pediatrics 106 (2000) 659-671
56. Foix-L'Helias L., Marret S., Ancel P.Y., et al. Impact of the use of antenatal corticosteroids on mortality, cerebral lesions and 5-year neurodevelopmental outcomes of very preterm infants: the EPIPAGE cohort study. Br J Obstet Gynaecol 115 (2008) 275-282
57. NIH consensus development panel on the effect of corticosteroids for fetal maturation on perinatal outcomes. Effect of corticosteroids for fetal maturation on perinatal outcomes. J Am Med Assoc 273 (1995) 413-418
58. Hassan A.H., von Rosenstiel P., Patchev V.K., Holsboer F., and Almeida O.F. Exacerbation of apoptosis in the dentate gyrus of the aged rat by dexamethasone and the protective role of corticosterone. Exp Neurol 140 (1996) 43-52
59. Jobe A.H., and Soll R.F. Choice and dose of corticosteroid for antenatal treatments. Am J Obstet Gynecol 190 (2004) 878-881
60. Lee B.H., Stoll B.J., McDonald S.A., and Higgins R.D. Neurodevelopmental outcomes of extremely low birth weight infants exposed prenatally to dexamethasone versus betamethasone. Pediatrics 121 (2008) 289-296
61. Spinillo A., Viazzo F., Colleoni R., Chiara A., Maria Cerbo R., and Fazzi E. Two-year infant neurodevelopmental outcome after single or multiple antenatal courses of corticosteroids to prevent complications of prematurity. Am J Obstet Gynecol 191 (2004) 217-224
62. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consens Statement 12 (1994) 1-24
63. Vermillion S.T., Soper D.E., and Newman R.B. Is betamethasone effective longer than 7 days after treatment?. Obstet Gynecol 97 (2001) 491-493
64. Sehdev H.M., Abbasi S., Robertson P., et al. The effects of the time interval from antenatal corticosteroid exposure to delivery on neonatal outcome of very low birth weight infants. Am J Obstet Gynecol 191 (2004) 1409-1413
65. Peaceman A.M., Bajaj K., Kumar P., and Grobman W.A. The interval between a single course of antenatal steroids and delivery and its association with neonatal outcomes. Am J Obstet Gynecol 193 (2005) 1165-1169
66. Ring A.M., Garland J.S., Stafeil B.R., Carr M.H., Peckman G.S., and Pircon R.A. The effect of a prolonged time interval between antenatal corticosteroid administration and delivery on outcomes in preterm neonates: a cohort study. Am J Obstet Gynecol 196 (2007) 457.e1-457.e6
67. Brocklehurst P., Gates S., McKenzie-McHarg K., Alfirevic Z., and Chamberlain G. Are we prescribing multiple courses of antenatal corticosteroids? A survey of practice in the UK. Br J Obstet Gynaecol 106 (1999) 977-979
68. French N.P., Hagan R., Evans S.F., Godfrey M., and Newnham J.P. Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol 180 (1999) 114-121
69. Banks B.A., Cnaan A., Morgan M.A., et al. Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotropin-Releasing Hormone Study Group. Am J Obstet Gynecol 181 (1999) 709-717
70. Cheong J.L., Hunt R.W., Anderson P.J., et al. Head growth in preterm infants: correlation with magnetic resonance imaging and neurodevelopmental outcome. Pediatrics 121 (2008) e1534-e1540
71. Anonymous. Antenatal corticosteroids revisited: repeat courses - National Institutes of Health Consensus Development Conference Statement, August 17-18, 2000. Obstet Gynecol 98 (2001) 144-150
72. French N.P., Hagan R., Evans S.F., Mullan A., and Newnham J.P. Repeated antenatal corticosteroids: effects on cerebral palsy and childhood behavior. Am J Obstet Gynecol 190 (2004) 588-595
73. Thorp J.A., O'Connor M., Belden B., Etzenhouser J., Hoffman E.L., and Jones P.G. Effects of phenobarbital and multiple-dose corticosteroids on developmental outcome at age 7 years. Obstet Gynecol 101 (2003) 363-373
74. Wapner R.J., Sorokin Y., Mele L., et al. Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med 357 (2007) 1190-1198
75. Crowther C.A., Doyle L.W., Haslam R.R., Hiller J.E., Harding J.E., and Robinson J.S. Outcomes at 2 years of age after repeat doses of antenatal corticosteroids. N Engl J Med 357 (2007) 1179-1189